These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30448168)

  • 1. "Baumkuchen" Structure Assessed by Optical Coherence Tomography After 15 Years of Bare-Metal Stent Implantation.
    Yukimitsu N; Hioki H; Kyono H; Nagura F; Kozuma K
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2431-2432. PubMed ID: 30448168
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
    Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
    Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
    [No Abstract]   [Full Text] [Related]  

  • 4. Very early in-stent neoatherosclerosis assessed by optical coherence tomography.
    Vergara-Martel A; Pizzato PE; Dallan LAP; Pereira GTR; Richmond HCT; Attizzani GF; Jones MR
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1793-1794. PubMed ID: 31175526
    [No Abstract]   [Full Text] [Related]  

  • 5. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
    EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex, diffuse in-stent atherosclerosis over a decade following bare metal stenting.
    Lau JK; Alcock RF; Brieger D; Lowe HC
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e69-70. PubMed ID: 26247273
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Utility of Combined Optical Coherence Tomography and Near-Infrared Spectroscopy for Assessing the Mechanism of Very Late Stent Thrombosis.
    Ino Y; Kubo T; Kameyama T; Shimamura K; Terada K; Matsuo Y; Kitabata H; Shiono Y; Kashiwagi M; Kuroi A; Maniwa N; Ota S; Ozaki Y; Tanaka A; Hozumi T; Akasaka T
    JACC Cardiovasc Imaging; 2018 May; 11(5):772-775. PubMed ID: 29361480
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
    Sato T; Richardt G; Abdel-Wahab M
    Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
    [No Abstract]   [Full Text] [Related]  

  • 10. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
    Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Mechanisms in 1 In-Stent Restenosis Assessed by Optical Coherence Tomography.
    Lu WD; Huang CW; Li YH; Chen JY
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2340-2341. PubMed ID: 29102578
    [No Abstract]   [Full Text] [Related]  

  • 13. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A broken promise: 4-year optical coherence tomography follow-up of a bioresorbable vascular scaffold.
    Versaci F; Vizzari G; Prati F; Biondi-Zoccai G
    J Cardiovasc Med (Hagerstown); 2020 May; 21(5):398-400. PubMed ID: 32243342
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.
    Nakajima Y; Itoh T; Morino Y
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E137-42. PubMed ID: 26011018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
    Rheude TA; Xhepa E; Byrne RA
    Catheter Cardiovasc Interv; 2017 May; 89(6):E181-E184. PubMed ID: 27527355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early restenose in a polymer-free Biolimus A9-coated stent (BioFreedom): A case report based on optical coherence tomography.
    Ellert J; Antonsen L; Jensen LO
    Cardiovasc Revasc Med; 2017; 18(3):207-211. PubMed ID: 27650886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis After Drug-Eluting Stent Implantation in a Patient With Polycythemia Vera: Optical Coherence Tomography and Pathological Findings.
    Fujino A; Hao H; Kajimoto N; Kawakami R; Imanaka T; Fujii K; Abe T; Ishihara M; Hirota S
    JACC Cardiovasc Interv; 2015 Jun; 8(7):e111-2. PubMed ID: 26003023
    [No Abstract]   [Full Text] [Related]  

  • 20. Subintimal Crush of an Occluded Stent to Recanalize a Chronic Total Occlusion Due to In-Stent Restenosis: Insights From a Multimodality Imaging Approach.
    Capretti G; Mitomo S; Giglio M; Carlino M; Colombo A; Azzalini L
    JACC Cardiovasc Interv; 2017 Apr; 10(8):e81-e83. PubMed ID: 28365267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.